Search Results 101-110 of 183 for ❌레고주소 [원탑보증.com/가입코드 111] 올인구조대 ❌

  1. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or ...

  2. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  3. Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    The purpose of this study is to determine if ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and ...

  4. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    This phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate ...

  5. ... 111 301000059,HC AMPHI WESTERN BLOT,391 301000060,HC AMYLASE ASSAY,55 301000061,HC AMYLASE PANCREATIC ASSAY,61 301000062,HC AMYLASE URINE ASSAY,60 301000063 ...

  6. Intracardiac Flow Assessment in Cardiac Amyloidosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study - Mayo Clinic

    The purpose of this study is to evaluate the effects of RT234 on exercise parameters assessed by a specialized exercise test (Cardiopulmonary Exercise Test or ...

  8. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    The purpose of this study is to assess the effectiveness of Revita® DMR for improving HbA1c to ≤ 7% without the need of insulin in subjects with T2D compared ...

  9. Registry for Alzheimer’s Prevention in Wisconsin - Mayo Clinic

    About this study. The purpose of this study is to determine whether Alzheimer's Disease related cognitive trajectories can be identified in midlife and ...

  10. Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) - Mayo Clinic

    The purpose of this study is to collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved ...